This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Kuraray Co., Ltd., Kyoto University, Tohoku University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2021
Title: Rieko Ohki: Innovator in Pancreatic Islet Cell Research
Introduction
Rieko Ohki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biomedical engineering, particularly in the area of pancreatic islet cell research. Her innovative work has the potential to impact diabetes treatment and regenerative medicine.
Latest Patents
Rieko Ohki holds a patent for a method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3. This invention provides a method for preparing a graft material containing organ or tissue cells, specifically cells that have inhibited PHLDA3 expression. This advancement could lead to improved outcomes in cell transplantation therapies.
Career Highlights
Throughout her career, Rieko Ohki has been associated with prestigious institutions such as Tohoku University and Kyoto University. Her work at these universities has allowed her to collaborate with leading researchers and contribute to groundbreaking studies in her field.
Collaborations
Rieko has worked alongside notable colleagues, including Shoichiro Sumi and Naoaki Sakata. These collaborations have enriched her research and expanded the impact of her inventions.
Conclusion
Rieko Ohki's contributions to pancreatic islet cell research exemplify the importance of innovation in medical science. Her patented methods and collaborations highlight her role as a key figure in advancing therapeutic techniques for diabetes treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile